Anti-MCAM antibodies and associated methods of use
Abstract:
The invention provides anti-MCAM antibodies that inhibit the ability of human MCAM to bind a laminin alpha-4 chain. The invention also provides pharmaceutical compositions, methods of generating such antibodies, and their use in the manufacture of medicaments for treatment of neuroinflammatory disease, autoimmune disease, or cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0